Get started
RocketTickers

AMPH Receives FDA Approval for Succinylcholine Chloride Injectio

Long
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)  
RocketTickers  
NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc.
Beyond Technical Analysis
2
0
beyondta
AMPH: Amphastar Pharmaceuticals, Inc.
2020-06-09 06:00:10
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.